Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jacoline C. Bouvy, Pall Jonsson, Diana O’Rourke, Antonella Santuccione Chadha, Niklas Hedberg, Amr Makady, Entela Xoxi, Christine Gispen-de Wied, Anja Schiel, Raj Long, John Gallacher

Journal title: CNS Drugs

Journal number: 32/12

Journal publisher: Adis International Ltd.

Published year: 2018

Published pages: 1085-1090

DOI identifier: 10.1007/s40263-018-0581-x

ISSN: 1172-7047